NEK9 and osteosarcoma: To validate NEK9 as a RSR protein, we examined for phosphorylation of H2AX Ser139 (γH2AX), an early marker for DNA damage, following NEK9 knockdown in U2OS human osteosarcoma cells (Figure 3E).